Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
Saved in:
| Title: | Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound. |
|---|---|
| Authors: | Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Vaidya M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Park H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Duell DM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Lum R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hesselgesser J; Gilead Sciences, Inc., Foster City, CA, USA., Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA., Li Y; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Borate BR; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. pickerl@ohsu.edu., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. lifsonj@mail.nih.gov. |
| Source: | Nature medicine [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1430-1440. Date of Electronic Publication: 2018 Aug 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30082858 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Vaidya+M%22">Vaidya M</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Fukazawa+Y%22">Fukazawa Y</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Duell+DM%22">Duell DM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Lum+R%22">Lum R</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+CM%22">Hughes CM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ventura+AB%22">Ventura AB</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ainslie+E%22">Ainslie E</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ford+JC%22">Ford JC</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Morrow+D%22">Morrow D</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Gilbride+RM%22">Gilbride RM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Legasse+AW%22">Legasse AW</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hesselgesser+J%22">Hesselgesser J</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Geleziunas+R%22">Geleziunas R</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bosche+WJ%22">Bosche WJ</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Borate+BR%22">Borate BR</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. pickerl@ohsu.edu.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. lifsonj@mail.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1430-1440. <i>Date of Electronic Publication: </i>2018 Aug 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30082858 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-018-0130-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1430 Titles: – TitleFull: Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Okoye AA – PersonEntity: Name: NameFull: Hansen SG – PersonEntity: Name: NameFull: Vaidya M – PersonEntity: Name: NameFull: Fukazawa Y – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Duell DM – PersonEntity: Name: NameFull: Lum R – PersonEntity: Name: NameFull: Hughes CM – PersonEntity: Name: NameFull: Ventura AB – PersonEntity: Name: NameFull: Ainslie E – PersonEntity: Name: NameFull: Ford JC – PersonEntity: Name: NameFull: Morrow D – PersonEntity: Name: NameFull: Gilbride RM – PersonEntity: Name: NameFull: Legasse AW – PersonEntity: Name: NameFull: Hesselgesser J – PersonEntity: Name: NameFull: Geleziunas R – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Oswald K – PersonEntity: Name: NameFull: Shoemaker R – PersonEntity: Name: NameFull: Fast R – PersonEntity: Name: NameFull: Bosche WJ – PersonEntity: Name: NameFull: Borate BR – PersonEntity: Name: NameFull: Edlefsen PT – PersonEntity: Name: NameFull: Axthelm MK – PersonEntity: Name: NameFull: Picker LJ – PersonEntity: Name: NameFull: Lifson JD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2018 Sep Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 24 – Type: issue Value: 9 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |